Rev. Bras. Reumatol. vol.49 número3

Due to the fact that patients with APS suffer an increased risk of atherosclerotic disease and thrombosis and the studies in primary APS being scarce, the objective of the

The treatment of systemic sclerosis, particularly the diffuse form of the disease, remains a great medical challenge and various therapies were evaluated with the

Diminished expression of complement regulatory proteins (CD55 and CD59) in lymphocytes from systemic lupus erythematosus patients with lymphopenia. Arora M, Arora R, Tiwari

However, even when the disease is under control and metabolic abnormalities are minimized, its consequences, such as reduction of body cell mass, gain of fat mass and even

By presenting this case, we concluded that the presence of acquired factor VIII inhibitors should be investigated when patients with autoimmune diseases develop

Camurati-Engelmann disease or progressive diaphyseal dysplasia is a rare autosomal dominant genetic disease of the bone metabolism, characterized by limb pain and muscular

Relevant exams are shown below: (Nov/2001) normochromic/normocytic anemia; C-reactive protein:69.5 mg/dL; erythrocyte sedimentation rate: 90 mm/h; negative

2) Alguns autores sugerem biomarcadores indicativos de reação infusional, como a presença de anticorpos antinucleares. Outros autores fazem distinção entre a presença de